You have full access to this article via your institution.

Results from the PATHFINDER 2 trial of Grail's blood test for multiple cancers have shown greater efficacy and a lower rate of false alarms than in an earlier trial of the technology. The Galleri ...

You're currently following this author! Want to unfollow? Unsubscribe via the link in your email. Follow Brent D. Griffiths Every time Brent D. Griffiths publishes a story, you’ll get an alert ...

LIMERICK — The public got its first look at a 1.4-million-square-foot data center proposal for 192 acres across from the Philadelphia Outlets Thursday when it was unveiled to the township planning ...

Retro Review video series is where we’ll go back through time and look at some iconic pieces of equipment to see if they still stack up against their modern day ...

Sahakol Equipment Public Co. Ltd. engages in the provision of mining and construction solutions. It offers mine planning and logistics; open pit mining operations; mining consultancy; and heavy duty ...

Your guide to what Trump’s second term means for Washington, business and the world Donald Trump posted some of December’s US jobs figures hours before the release of the economic report, giving ...

OpenAI plans to start testing ads inside ChatGPT in the coming weeks, marking a significant shift for one of the world’s most widely used AI products. The company announced Friday that initial ad ...

Zack Sigel is a writer and editor based in New York City. He has been managing editor at Policygenius and M1 Finance, where he led teams specialized in writing about business and finance, and he has ...